source
- FDA to review and potentially overhaul PMTA rules amid lawsuit and illicit market concernsFDA announced it is reviewing its experience with the Premarket Tobacco Product Application (PMTA) rule and recent court actions. The agency cites the growth of an illicit market and rapid introdu…
- Mirum reports Phase 3 success for its acquired hepatitis D therapyMirum Pharmaceuticals announced that its recently acquired chronic hepatitis delta drug met its primary endpoint in a Phase 3 trial. The study tested a once-weekly 300 mg injection, and more than…